Rchr
J-GLOBAL ID:201801002635579049
Update date: Mar. 29, 2025 Akahane Takemi
アカハネ タケミ | Akahane Takemi
- Fumimasa Tomooka, Koh Kitagawa, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Kosuke Kaji, Shohei Asada, Shinya Sato, et al. Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction. DEN open. 2025. 5. 1. e404
- Jun-Ichi Hanatani, Koh Kitagawa, Fumimasa Tomooka, Shohei Asada, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Shinya Sato, Akihiko Shibamoto, Yuki Fujimoto, et al. Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan. DEN open. 2025. 5. 1. e371
- Akihiko Shibamoto, Tadashi Namisaki, Satoshi Iwai, Fumimasa Tomooka, Takahiro Kubo, Aritoshi Koizumi, Misako Tanaka, Takuya Matsuda, Takashi Inoue, Yuki Tsuji, et al. Prognostic significance of skeletal muscle mass in patients with alcohol-related cirrhosis. Hepatology Research. 2025
- Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Takemi Akahane, et al. Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis. Journal of gastroenterology. 2025
- Kosuke Kaji, Soichi Takeda, Satoshi Iwai, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Antioxidants. 2024
- Takuya Matsuda, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Aritoshi Koizumi, Misako Tanaka, Nobuyuki Yorioka, Yuki Tsuji, Koh Kitagawa, Shinya Sato, et al. Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity. Heliyon. 2024. 10. 19. e38647
- 浪崎 正, 辻 裕樹, 西村 尚樹, 藤永 幸久, 西村 典久, 佐藤 慎哉, 北川 洸, 鍛治 孝祐, 瓦谷 英人, 赤羽 たけみ, et al. 腸管透過性マーカーによる進行肝細胞癌に対するアテゾリブマブ+ベバシズマブ併用療法の治療効果予測の試み. 肝臓. 2024. 65. Suppl.2. A666-A666
- Yoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, et al. Clinical characteristics of steatotic liver disease categories in a large cohort of Japanese health checkup participants. Gastro Hep Advances. 2024
- Hirayuki Enomoto, Norio Akuta, Hayato Hikita, Goki Suda, Jun Inoue, Nobuharu Tamaki, Kiyoaki Ito, Takemi Akahane, Tomokazu Kawaoka, Asahiro Morishita, et al. Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021. Hepatology Research. 2024
- Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Takuya Matsuda, Misako Tanaka, Nobuyuki Yorioka, Yuki Tsuji, Koh Kitagawa, Shinya Sato, et al. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease. World journal of gastroenterology. 2024. 30. 28. 3428-3446
- Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, et al. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
- Takahiro Kubo, Norihisa Nishimura, Kosuke Kaji, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Junya Suzuki, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, et al. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International Journal of Molecular Sciences. 2024
- 藤永 幸久, 岩井 聡始, 藤本 優樹, 北川 洸, 西村 典久, 鍛治 孝祐, 瓦谷 英人, 赤羽 たけみ, 美登路 昭, 吉治 仁志. 十二指腸非乳頭部腫瘍の内視鏡治療の最前線 表在性非乳頭部十二指腸上皮性腫瘍に対するUEMRとEMRの比較. 日本消化器病学会雑誌. 2024. 121. 臨増総会. A202-A202
- 友岡 文優, 鍛治 孝祐, 北川 洸, 西村 典久, 浪崎 正, 赤羽 たけみ, 美登路 昭, 吉治 仁志. 胆道癌の分子異常と治療の新展開 スルフォラファンはHDAC阻害によりゲムシタビンの肝内胆管癌抑制効果を増強させる. 日本消化器病学会雑誌. 2024. 121. 臨増総会. A226-A226
- Shohei Asada, Kosuke Kaji, Norihisa Nishimura, Aritoshi Koizumi, Takuya Matsuda, Misako Tanaka, Nobuyuki Yorioka, Shinya Sato, Koh Kitagawa, Tadashi Namisaki, et al. Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats. Cells. 2024
- Misako Tanaka, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Aritoshi Koizumi, Takuya Matsuda, Nobuyuki Yorioka, Yuki Tsuji, Yukihisa Fujinaga, Shinya Sato, et al. Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis. Biochimica et biophysica acta. Molecular cell research. 2024. 1871. 2. 119649-119649
- Junya Suzuki, Tadashi Namisaki, Hiroaki Takya, Kosuke Kaji, Norihisa Nishimura, Akihiko Shibamoto, Shohei Asada, Takahiro Kubo, Satoshi Iwai, Fumimasa Tomooka, et al. ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. International Journal of Molecular Sciences. 2024
- Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, et al. VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis. Digestive Diseases and Sciences. 2024
- Chihiro Takeuchi, Junichi Sato, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Akiko Sasaki, Takemi Akahane, Rika Aoki, Shigemi Nakajima, Masayoshi Ito, Mitsue Yamamichi, et al. Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation. Journal of gastroenterology. 2023
- Misako Tanaka, Takemi Akahane, Hideto Kawaratani, Nobuyuki Yorioka, Aritoshi Koizumi, Shohei Asada, Takuya Matsuda, Satoshi Iwai, Yuki Tsuji, Yukihisa Fujinaga, et al. Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Return to Previous Page